Pubblicazioni scientifiche

Cancella testo

Open Access

1323 pubblicazioni

Gasparrini S.; Mazzucchelli R.; Scarpelli M.; Massari F.; Raspollini M.R.; Lopez-Beltran A.; Cheng L.; Montironi R., Prostate cancer grading in 2016, «MINERVA UROLOGICA E NEFROLOGICA», 2017, 69, pp. 1 - 4 [Articolo in rivista]
Cimadamore A.; Gasparrini S.; Scarpelli M.; Doria A.; Mazzucchelli R.; Massari F.; Cheng L.; Lopez-Beltran A.; Montironi R., Epigenetic modifications and modulators in prostate cancer, «CRITICAL REVIEWS IN ONCOGENESIS», 2017, 22, pp. 439 - 450 [Articolo in rivista]
Montironi R.; Lopez-Beltran A.; Cheng L.; Gasparrini S.; Montironi M.A.; Massari F.; Scarpelli M.; Montorsi F., Re: Kenneth A. Iczkowski's Letter to the Editor re: Re: Rodolfo Montironi, Silvia Gasparrini, Roberta Mazzucchelli, et al's Letter to the Editor re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738–9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides. Eur Urol 2017;71:e73–5, «EUROPEAN UROLOGY», 2017, 72, pp. 37 - 38 [Articolo in rivista]
Munari E.; Cima L.; Massari F.; Bertoldo F.; Porcaro A.B.; Calio A.; Riva G.; Ciocchetta E.; Ciccarese C.; Modena A.; Iacovelli R.; Sava T.; Eccher A.; Ghimenton C.; Tortora G.; Artibani W.; Novella G.; Bogina G.; Zamboni G.; Sanguedolce F.; D'Amuri A.; Martignoni G.; Brunelli M., Cathepsin K expression in castration-resistant prostate carcinoma: A therapeutical target for patients at risk for bone metastases, «THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS», 2017, 32, pp. 243 - 247 [Articolo in rivista]
Ciccarese C.; Iacovelli R.; Bria E.; Modena A.; Massari F.; Brunelli M.; Fantinel E.; Bimbatti D.; Zamboni G.A.; Artibani W.; Tortora G., The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: A meta-analysis of current studies, «IMMUNOTHERAPY», 2017, 9, pp. 579 - 587 [Articolo in rivista]
Montironi R.; Gasparrini S.; Cimadamore A.; Mazzucchelli R.; Massari F.; Cheng L.; Lopez-Beltran A.; Moch H.; Montorsi F.; Scarpelli M., Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View, «EUROPEAN UROLOGY. SUPPLEMENTS», 2017, 16, pp. 232 - 240 [Articolo in rivista]
Gasparrini S.; Cimadamore A.; Mazzucchelli R.; Scarpelli M.; Massari F.; Raspollini M.R.; Galosi A.B.; Lopez-Beltran A.; Cheng L.; Montironi R., Pathology and molecular updates in tumors of the prostate: towards a personalized approach, «EXPERT REVIEW OF MOLECULAR DIAGNOSTICS», 2017, 17, pp. 781 - 789 [Articolo in rivista]
Massari F.; Di Nunno V.; Ciccarese C.; Graham J.; Porta C.; Comito F.; Cubelli M.; Iacovelli R.; Heng D.Y.C., Adjuvant therapy in renal cell carcinoma, «CANCER TREATMENT REVIEWS», 2017, 60, pp. 152 - 157 [Articolo in rivista]
Petrylak D.P.; de Wit R.; Chi K.N.; Drakaki A.; Sternberg C.N.; Nishiyama H.; Castellano D.; Hussain S.; Flechon A.; Bamias A.; Yu E.Y.; van der Heijden M.S.; Matsubara N.; Alekseev B.; Necchi A.; Geczi L.; Ou Y.-C.; Coskun H.S.; Su W.-P.; Hegemann M.; Percent I.J.; Lee J.-L.; Tucci M.; Semenov A.; Laestadius F.; Peer A.; Tortora G.; Safina S.; del Muro X.G.; Rodriguez-Vida A.; Cicin I.; Harputluoglu H.; Widau R.C.; Liepa A.M.; Walgren R.A.; Hamid O.; Zimmermann A.H.; Bell-McGuinn K.M.; Powles T.; Wong S.-L.S.; Tan T.H.; Hovey E.J.; Clay T.D.; Ng S.S.W.; Rutten A.; Machiels J.-P.; Dumez H.; Cheng S.Y.-S.; Ferrario C.; Sengeloev L.; Jensen N.V.; Thibault C.; Laguerre B.; Joly F.; Flechon A.; Culine S.; Becht C.; Niegisch G.; Stockle M.; Grimm M.-O.; Gakis G.; Schultze-Seemann W.; Kalofonos H.; Mavroudis D.; Papandreou C.; Karavasilis V.; Revesz J.; Geczi L.; Rosenbaum E.; Leibowitz-Amit R.; Kejzman D.; Sarid D.; Scagliotti G.V.; Bracarda S.; Massari F.; Osawa T.; Miyajima N.; Shinohara, Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial, «THE LANCET», 2017, 390, pp. 2266 - 2277 [Articolo in rivista]
Del Re M.; Fogli S.; Derosa L.; Massari F.; De Souza P.; Crucitta S.; Bracarda S.; Santini D.; Danesi R., The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide, «CANCER TREATMENT REVIEWS», 2017, 55, pp. 71 - 82 [Articolo in rivista]
Massari F.; Ciccarese C.; Bria E.; Porta C.; La Russa F.; Knuutila S.; Artibani W.; Porcaro A.B.; Bimbatti D.; Modena A.; Sava T.; Tortora G.; Cheng L.; Eccher A.; Cima L.; Pedron S.; Ghimenton C.; Martignoni G.; Brunelli M., Reprofiling metastatic samples for chromosome 9p and 14q aberrations as a strategy to overcome tumor heterogeneity in clear-cell renal cell carcinoma, «APPLIED IMMUNOHISTOCHEMISTRY AND MOLECULAR MORPHOLOGY», 2017, 25, pp. 39 - 43 [Articolo in rivista]
Montironi R.; Cimadamore A.; Massari F.; Montironi M.A.; Lopez-Beltran A.; Cheng L.; Montorsi F.; Scarpelli M., Whole slide imaging of large format histology in prostate pathology: Potential for information fusion, «ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE», 2017, 141, pp. 1460 - 1461 [Articolo in rivista]
Cimadamore A.; Scarpelli M.; Piva F.; Massari F.; Gasparrini S.; Doria A.; Cheng L.; Lopez-Beltran A.; Montironi R., Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets, «FUTURE ONCOLOGY», 2017, 13, pp. 1105 - 1114 [Articolo in rivista]
Montironi R.; Gasparrini S.; Mazzucchelli R.; Massari F.; Cheng L.; Lopez-Beltran A.; Montorsi F.; Scarpelli M., Re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738–9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides, «EUROPEAN UROLOGY», 2017, 71, pp. 73 - 75 [Articolo in rivista]
Ciccarese C.; Massari F.; Blanca A.; Tortora G.; Montironi R.; Cheng L.; Scarpelli M.; Raspollini M.R.; Vau N.; Fonseca J.; Lopez-Beltran A., Tp53 and its potential therapeutic role as a target in bladder cancer, «EXPERT OPINION ON THERAPEUTIC TARGETS», 2017, 21, pp. 401 - 414 [Articolo in rivista]
Ciccarese C.; Montironi R.; Iacovelli R.; Massari F., Localized prostate cancer genotyping: Another step towards personalized therapy, «TRANSLATIONAL CANCER RESEARCH», 2017, 6, pp. 246 - 248 [Articolo in rivista] Open Access
Di Nunno V.; Cubelli M.; Massari F., The role of the MET/AXL pathway as a new target for multikinase inhibitors in renal cell carcinoma, «EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT», 2017, 2, pp. 169 - 175 [Articolo in rivista]
Ciccarese C.; Di Nunno V.; Iacovelli R.; Massari F., Future perspectives for personalized immunotherapy in renal cell carcinoma, «EXPERT OPINION ON BIOLOGICAL THERAPY», 2017, 17, pp. 1049 - 1052 [Articolo in rivista]
Conteduca V.; Caffo O.; Lolli C.; Aieta M.; Scarpi E.; Bianchi E.; Maines F.; Schepisi G.; Salvi S.; Massari F.; Carrozza F.; Veccia A.; Chiuri V.E.; Campadelli E.; Facchini G.; De Giorgi U., Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone, «THE PROSTATE», 2017, 77, pp. 1012 - 1019 [Articolo in rivista]
Ciccarese C.; Iacovelli R.; Brunelli M.; Massari F.; Bimbatti D.; Fantinel E.; De Marco V.; Porcaro A.B.; Martignoni G.; Artibani W.; Tortora G., Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies, «EUROPEAN JOURNAL OF CANCER», 2017, 83, pp. 237 - 246 [Articolo in rivista]